94 related articles for article (PubMed ID: 3209918)
1. [Treatment of advanced cervical cancer with sequential administration of OK-432].
Yakabe A; Sugino N; Yamashita S; Kinashi N; Ito T; Kamei T; Takasaki A
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1911-4. PubMed ID: 3209918
[No Abstract] [Full Text] [Related]
2. [Local injection of OK-432 and mitomycin C into vulvar cancer responding poorly to bleomycin and linac irradiation].
Yakabe A; Yamashita S; Kinashi N; Ito T
Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):758-62. PubMed ID: 2444661
[No Abstract] [Full Text] [Related]
3. [Peri-focal administration of OK-432 combined with radiotherapy in the treatment of esophageal cancer].
Mukai M; Hiura T; Yamazaki Y; Nakajima K; Mikoshiba Y; Kasuya S; Nagao K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1700-5. PubMed ID: 6870311
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
[TBL] [Abstract][Full Text] [Related]
5. [A case of bronchial carcinoma showing regression upon intratumoral administration of OK-432].
Onodera A; Miura K; Sasaki M; Sugiyama N; Kurokawa H; Shioya T; Kanazawa T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):341-4. PubMed ID: 3341793
[TBL] [Abstract][Full Text] [Related]
6. [Immunochemotherapy of recurrent and advanced uterine and ovarian cancer using cisplatin].
Matsuura K; Shibata S; Kawasaki N; Ushijima H; Katabuchi H; Kamikawa S; Koyama N; Fukuda O; Oka M; Inoue S; Munemura M; Nakayama M; Maeyama M
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):981-91. PubMed ID: 6191670
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
Kodama M; Tanaka T
Hiroshima J Med Sci; 1983 Jun; 32(2):167-71. PubMed ID: 6618899
[No Abstract] [Full Text] [Related]
8. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
[No Abstract] [Full Text] [Related]
9. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer].
Fujii M; Ishikawa M; Toki H
Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
[TBL] [Abstract][Full Text] [Related]
11. [Chemo-endocrine-immuno therapy with adriamycin, tamoxifen and OK-432 for advanced breast cancer].
Sawai K; Takahashi S; Izumi H; Kato G; Takenaka A; Shinbata O; Tokuda H
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1315-20. PubMed ID: 6096466
[No Abstract] [Full Text] [Related]
12. [Clinical investigation of intratumoral OK-432 administration].
Shimada K; Tabuse K; Kono N; Katsumi M; Yamamoto H; Yamamoto Y; Endo A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1844-9. PubMed ID: 6882008
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies of long-term administration of OK-432 in patients with gynecologic cancer].
Mano T; Kawamoto K; Miyake T; Torigoe T
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1439-45. PubMed ID: 2685142
[TBL] [Abstract][Full Text] [Related]
14. [Changes in peripheral lymphocyte subsets before and after OK-432 administration in liver cancer].
Yamamoto S; Omoto K; Yamamoto R; Ideguchi S; Oumi T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1077-8. PubMed ID: 3963851
[No Abstract] [Full Text] [Related]
15. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
[TBL] [Abstract][Full Text] [Related]
16. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
Wakida K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
[TBL] [Abstract][Full Text] [Related]
17. The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
Sakamoto J; Kondo T; Kamei H; Ichihashi H; Yamamura Y
Nagoya J Med Sci; 1979 Dec; 42(1-2):27-36. PubMed ID: 530302
[No Abstract] [Full Text] [Related]
18. [Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
Inoue H; Kobayashi H; Kajiya Y; Hidaka H; Ikeda K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):620-2. PubMed ID: 3006597
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
Nio Y; Nakamoto K; Tanaka A; Kikuchi S; Henmi K
Nihon Gan Chiryo Gakkai Shi; 1980 Apr; 15(2):161-5. PubMed ID: 7400644
[No Abstract] [Full Text] [Related]
20. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
